These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8814054)

  • 1. Antiphospholipid antibodies: new complexities and new assays.
    Emlen W
    Arthritis Rheum; 1996 Sep; 39(9):1441-3. PubMed ID: 8814054
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiphospholipid antibodies and antiphospholipid syndrome in juvenile lupus erythematosus].
    Romicka AM; Gazda A; Zabek J; Wojciechowska B
    Pol Arch Med Wewn; 2006 May; 115(5):477-80. PubMed ID: 17195365
    [No Abstract]   [Full Text] [Related]  

  • 4. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
    Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
    J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies. Where do they come from? Where do they go?
    Alarcón-Segovia D; Cabral AR
    J Rheumatol; 1994 Jun; 21(6):982-9. PubMed ID: 7932445
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiphospholipid antibodies--middle aged but robust.
    Harris EN; Gharavi A; Asherson RA; Khamashta MA; Hughes GR
    J Rheumatol; 1994 Jun; 21(6):978-81. PubMed ID: 7932444
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombosis and antiphospholipid antibodies--an evolving story.
    Ryan P; Street A
    Aust N Z J Med; 1993 Apr; 23(2):148-50. PubMed ID: 8517838
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiphospholipid, anti-beta 2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome.
    Cuadrado MJ; Tinahones F; Camps MT; de Ramon E; Gómez-Zumaquero JM; Mujic F; Khamashta MA; Hughes GR
    QJM; 1998 Sep; 91(9):619-26. PubMed ID: 10024916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D; Boutière B; Sanmarco M
    Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
    Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
    Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cofactor-antiphospholipid antibodies relationship in patients with systemic lupus erythematosus and infertility women].
    Dons'koĭ BV; Chernyshov VP
    Lik Sprava; 2005 Dec; (8):43-6. PubMed ID: 16498782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-beta 2-glycoprotein I antibodies and thrombosis.
    Viard JP; Amoura Z; Bach JF
    Clin Rev Allergy Immunol; 1995; 13(1):67-72. PubMed ID: 7648351
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis.
    Reynaud Q; Lega JC; Mismetti P; Chapelle C; Wahl D; Cathébras P; Laporte S
    Autoimmun Rev; 2014 Jun; 13(6):595-608. PubMed ID: 24418303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could anti-beta 2 glycoprotein I antibodies potentiate antiphospholipid autoantibody activity?
    Cheng HM
    Am J Med; 1993 Nov; 95(5):552-3. PubMed ID: 8238078
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance to activated protein C in systemic lupus erythematosus patients with antiphospholipid antibodies.
    Matsuda J; Gohchi K; Tsukamoto M; Gotoh M; Saitoh N; Kawasugi K
    Eur J Haematol; 1994 Sep; 53(3):188-9. PubMed ID: 7925866
    [No Abstract]   [Full Text] [Related]  

  • 16. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
    Lee SS; Cho ML; Joo YS; Kim WU; Hong YS; Min JK; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association between anti-phospholipid antibodies and thrombotic complications in systemic lupus erythematosus].
    Nojima J
    Rinsho Byori; 2003 Mar; 51(3):239-47. PubMed ID: 12707997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid-protein antibodies: clinical use of laboratory test results (identification, predictive value, treatment).
    Triplett DA
    Haemostasis; 1996 Oct; 26 Suppl 4():358-67. PubMed ID: 8979140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimitochondrial antibodies in the antiphospholipid syndrome.
    Abuaf N; Laperche S; Carsique R; Meyer O; Deschamps A; Rajoely B; Johanet C; Homberg JC
    Clin Rev Allergy Immunol; 1995; 13(1):57-65. PubMed ID: 7648350
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.